Featured post
Thank you

Physician Appreciation Event – Save the date

Physician Appreciation 2014

Remember to save the date for the upcoming Physician Appreciation Event on Friday, October 17 at the Boulder Ridge Country Club.

RSVP by Friday, October 10
To RSVP Click Here

Fall Symposium

The Fall Symposium lectures will be held on October 22, 2014 and October 23, 2014.

Fall Hot Topics

Registration and lecture information can be found Here.

Pharmacy

Article outlining the principles of medication reconciliation

The institute for healthcare improvement has an article outlining the background and objectives for medication reconciliation.

Poor communication of medical information at transition points is responsible for as many as 50 percent of all medication errors

Stethoscope and computer keyboard

Upcoming Paragon Upgrades

The upgrades and upgrade dates include but are not limited to:

September 2014:

MPF Upgrade

  • Formerly known as HPF, the MPF upgrade will provide a better interface to view Medical Records and Sign Deficiencies.

November/December:

Paragon Version 12.1

A few highlights include:

  • Ability to edit a completed Medication Reconciliation
  • Ability to see unsigned orders on a patient and sign them while inside their chart

Spring 2015:

Paragon Version 13

  • In the Spring of 2015 Centegra plans to upgrade to Paragon Version 13.
  • All new interface with greater visibility of information on the front page
  • mobile device compatibility

More details to follow.

For any questions or concerns, please contact Michael Millare or Prapti Desai.

Infection prevention

Enterovirus D68 update

Enterovirus D68 (EV-D68) is one of many non-polio enteroviruses. Enterovirus D68 (EV-D68) infections are thought to occur less commonly than infections with other enteroviruses. EV-D68 was first identified in California in 1962. Compared with other enteroviruses, EV-D68 has been rarely reported in the United States for the last 40 years.

EV-D68 Infections Reported

Hospitals in Missouri and Illinois are seeing more children than usual with severe respiratory illness caused by enterovirus D68. Several other states are investigating clusters of children with severe respiratory illness, possibly due to enterovirus D68. CDC is watching this situation closely and helping the states with testing of specimens.

Symptoms

EV-D68 has been reported to cause mild to severe respiratory illness. However, the full spectrum of EV-D68 illness is not well-defined.

Transmission

EV-D68 is not frequently identified, so it is less studied and the ways it spreads are not as well-understood as other enteroviruses. EV-D68 causes respiratory illness, and the virus can be found in respiratory secretions such as saliva, nasal mucus, or sputum. The virus likely spreads from person to person when an infected person coughs, sneezes, or touches contaminated surfaces.

Treatment

  • There is no specific treatment for EV-D68 infections.
  • Many infections will be mild and self-limited, requiring only treatment of the symptoms.
  • Some people with severe respiratory illness caused by EV-D68 may need to be hospitalized and receive intensive supportive therapy.
  • No antiviral medications are currently available for treating of EV-D68 infections.

Prevention

  • There are no vaccines for preventing EV-D68 infections.
  • You can help protect yourself from respiratory illnesses by following these steps:
  • Wash hands often with soap and water for 20 seconds, especially after changing diapers
  • Avoid touching eyes, nose and mouth with unwashed hands
  • Avoid kissing, hugging, and sharing cups or eating utensils with people who are sick
  • Disinfect frequently touched surfaces, such as toys and doorknobs, especially if someone is sick

Laboratory Testing

Test to be ordered is “Enterovirus Molecular by PCR” from  ARUP .  Will be a Miscellaneous test in Paragon. 

Specimen: Respiratory-bronch wash, BAL, Nasopharyngeal aspirate, sputum or tracheal aspirate.  Volume is 1.5ml.

References

Pharmacy database reporting

Please report issues related to ambiguous Pharmacy orders appearing in CPOE to this link. This will help enhance the safety for our patients. A quick link will appear in the sidebar as well.

Outpatient clinic and CPC cancellation policy

In an effort to maximize clinical access and improve scheduling efficiencies, Centegra Health System will implement a new cancellation policy in outpatient clinics and Centegra Physician Care.  Effective Sept. 3, 2014 any cancellation made by a patient less than 24 hours in advance of  an appointment will be considered a missed appointment and will result in a cancellation fee of $25.  Continue reading